Status:
COMPLETED
Changes in Blood Lipids After Long-term Consumption of n-3 LC-PUFA-Enriched Dairy Products
Lead Sponsor:
University of Jena
Conditions:
Hypertriglyceridemia
Eligibility:
All Genders
43-69 years
Phase:
NA
Brief Summary
The study was performed to investigate the effects of n-3 LC-PUFA supplemented dairy products cardiovascular risk factors in hypertriglyceridemic patients.
Detailed Description
Recent studies suggest that n-3 LC-PUFA intake might be useful to prevent coronary heart diseases. As a precondition for participating in this study, the patients were provided information in writing...
Eligibility Criteria
Inclusion
- TAG values ≥ 150 mg/dl or ≥ 1.7 mmol/L
Exclusion
- blood diluted medications
- lipid lowering medications
- glucocorticoids
- gastrointestinal or metabolic diseases (e.g., diabetes mellitus, hyperthyroidism or hypothyroidism, hypercholesteremic patients with familial previous impacts)
- daily alcohol abuse
- taking dietary supplements (e. g., fish oil capsules, vitamin E)
- known allergies or foodstuff indigestibility
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT00639041
Start Date
April 1 2006
End Date
May 1 2007
Last Update
September 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Facility: University of Jena, Institute of Nutrition, Department of Nutritional Physiology
Jena, Thuringia, Germany, 07743